Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998 Nov; 178 Suppl 1:S109-12.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antibodies, Viral
Chickenpox Vaccine
Herpes Zoster
Herpesvirus 3, Human
Humans
Immunization, Secondary
In Vitro Techniques
Lymphocyte Activation
Middle Aged
Neuralgia
Time Factors
T-Lymphocytes
Vaccines, Attenuated

authors with profiles

Myron J Levin

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium